Funding
The Australasian Gastro-Intestinal Trials Group (AGITG) is a not-for-profit organisation.
For the AGITG, the contributions from government, industry, participating institutions, investments, donors and members provides the resource framework and the scope through which the company can pursue its objectives and central purpose.
As funding becomes more difficult to obtain, our focus is on achieving a balance of funding that is sustainable, flexible and diversified to meet our scientific opportunities.
To achieve balanced funding:
- We are expanding our international network and strengthening links with other successful organisations
- Instigating new initiatives, such as the AGITG Innovation Fund, that provide more opportunities for our members
- Collaborating with funding bodies to develop effective responses to the milestone management processes necessary for most clinical trials
- Continue developing community engagement and fundraising programs through the GI Cancer Institute.
For more information on current infrastructure grants and funding for specific research, please visit the Clinical Trials section and the latest Annual Report.
Funding Streams
Industry Sponsor Research 71%
Government 7%
Corporate Sponsorship – Events & Marketing 11%
Direct Fundraising 6%
Other 4%
Government 7%
Corporate Sponsorship – Events & Marketing 11%
Direct Fundraising 6%
Other 4%
Share